Meeting
2021 Gastrointestinal Cancers Symposium
Tumor bulk as a prognostic biomarker and predictor of benefit from anti-EGFR therapy in patients with metastatic colorectal cancer: Analysis of 476 patients from the ARCAD Clinical Trials Program.
Authors
Benjamin Adam Weinberg
Ruesch Center for the Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC
Benjamin Adam Weinberg , Manel Rakez , Benoist Chibaudel , Tim Maughan , Richard Adams , John Raymond Zalcberg , Axel Grothey , Takayuki Yoshino , Qian Shi , Aimery De Gramont , Dustin A. Deming
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Colorectal Cancer
Track
Colorectal Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Clinical Trial Registration Number
NCT00182715, NCT00640081
Citation
J Clin Oncol 39, 2021 (suppl 3; abstr 108)
DOI
10.1200/JCO.2021.39.3_suppl.108
Abstract #
108
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Response to epithelial growth factor receptor inhibitor (EGFRi) treatment in patients with early-onset, treatment-naïve metastatic colorectal cancer (mCRC): An ARCAD database analysis.
First Author: Zhaohui Jin
Poster
2022 ASCO Gastrointestinal Cancers Symposium
The prevalence of common KRAS variants and associated outcomes in patients with metastatic colorectal cancer (mCRC).
First Author: Laura W. Musselwhite
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Impact of KRAS mutation variants on clinicopathological features and outcomes in patients with metastatic pancreatic adenocarcinoma.
First Author: Chirag Patel
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Real-world clinicopathological and molecular characteristics, treatment patterns, and outcomes in patients with KRAS G12C–mutated metastatic colorectal cancer in AACR Project GENIE.
First Author: Hil Hsu